Colorectal cancer

Supporting evidence

• Surveillance report

• 2025 exceptional surveillance of ovarian cancer: recognition and initial management, colorectal cancer, and oesophago-gastric cancer: assessment and management in adults (NICE guidelines CG122, NG151 and NG83)

• Appendix A: Equality and health inequalities assessment (PDF 207 KB)

  Published:

  14 January 2025

• 2020 exceptional surveillance of lung cancer: diagnosis and management (NICE guideline NG122) and colorectal cancer (NICE guideline NG151)

• 2020 exceptional surveillance of colorectal cancer (NICE guideline NG151)

• Evidence review

• Evidence reviews – January 2020

• A1: Effectiveness of aspirin in the prevention of colorectal cancer in people with Lynch syndrome (PDF 918 KB)

  Published:

  29 January 2020

• B1: Use of molecular biomarkers to guide systemic therapy (PDF 1.26 MB)

  Published:

  29 January 2020

• C1: Treatment for early rectal cancer (PDF 970 KB)

  Published:

  29 January 2020

• C2: Preoperative radiotherapy and chemoradiotherapy for rectal cancer (PDF 1.82 MB)

  Published:

  29 January 2020

• C3: Optimal surgical technique for rectal cancer (PDF 2.79 MB)

  Published:

  29 January 2020

• C4: Deferral of surgery in people having neoadjuvant therapy for rectal cancer (PDF 419 KB)

  Published:

  29 January 2020

• C5: Effectiveness of exenterative surgery for locally advanced or recurrent rectal cancer (PDF 756 KB)

  Published:

  29 January 2020

• C6: Endoscopic resection alone for early colon cancer (PDF 677 KB)

  Published:

  29 January 2020

• C7: Preoperative chemotherapy for non-metastatic colon cancer (PDF 669 KB)

  Published:

  29 January 2020

• C8: Optimal duration of adjuvant chemotherapy for colorectal cancer (PDF 883 KB)

  Published:

  29 January 2020

• C9: Effectiveness of stenting for acute large bowel obstruction (PDF 1.18 MB)

  Published:

  29 January 2020

• D1: Surgery for asymptomatic primary tumour (PDF 831 KB)

  Published:

  29 January 2020

• D2A: Treatment for metastatic colorectal cancer in the liver amenable to treatment with curative intent (PDF 2.71 MB)

  Published:

  29 January 2020

• D2B: Optimal combination and sequence of treatments in patients presenting with metastatic colorectal cancer in the liver not amenable to treatment with curative intent (PDF 1.6 MB)

  Published:

  29 January 2020

• D3: Treatment for metastatic colorectal cancer in the lung amenable to local treatment (PDF 542 KB)

  Published:

  29 January 2020

• D4: Local and systemic treatments for metastatic colorectal cancer isolated in the peritoneum (PDF 569 KB)

  Published:

  29 January 2020

• E1: Follow-up to detect recurrence after treatment for non-metastatic colorectal cancer (PDF 2.25 MB)

  Published:

  29 January 2020

• E2: Optimal management of low anterior resection syndrome (PDF 348 KB)

  Published:

  29 January 2020

• E3: Information needs of people prior, during and after treatment for colorectal cancer (PDF 927 KB)

  Published:

  29 January 2020

• F1: Surgical volumes and outcomes for rectal cancer (PDF 1.56 MB)

  Published:

  29 January 2020

• Other supporting evidence

• Methods (PDF 530 KB)

  Published:

  29 January 2020

• Health economics (PDF 319 KB)

  Published:

  29 January 2020

• Glossary (PDF 197 KB)

  Published:

  29 January 2020

• NGA staff list (PDF 175 KB)

  Published:

  29 January 2020